Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.

about

Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.

Item

http://www.wikidata.org/entity/Q48590222

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Preclinical and clinical studi ...... the mixed chimerism approach.

@en

Preclinical and clinical studi ...... the mixed chimerism approach.

@nl

type

Item

label

Preclinical and clinical studi ...... the mixed chimerism approach.

@en

Preclinical and clinical studi ...... the mixed chimerism approach.

@nl

prefLabel

Preclinical and clinical studi ...... the mixed chimerism approach.

@en

Preclinical and clinical studi ...... the mixed chimerism approach.

@nl

P1476

Preclinical and clinical studi ...... the mixed chimerism approach.

@en

P2093

A B Cosimi

http://www.w3.org/2001/XMLSchema#string

David H Sachs

http://www.w3.org/2001/XMLSchema#string

Hajime Sasaki

http://www.w3.org/2001/XMLSchema#string

James Allan

http://www.w3.org/2001/XMLSchema#string

Joren C Madsen

http://www.w3.org/2001/XMLSchema#string

Tatsuo Kawai

http://www.w3.org/2001/XMLSchema#string

Tetsu Oura

http://www.w3.org/2001/XMLSchema#string

Thomas R Spitzer

http://www.w3.org/2001/XMLSchema#string

Yi-Bin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance

Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression.

Effect of tolerance versus chronic immunosuppression protocols on the quality of life of kidney transplant recipients.

HLA-mismatched renal transplantation without maintenance immunosuppression.

Alefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells.

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates

Strategies to improve long-term outcomes after renal transplantation.

Cardiovascular toxicities of immunosuppressive agents.

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

P31

scholarly article

P356

10.1016/J.HUMIMM.2017.11.008

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29175110

http://www.w3.org/2001/XMLSchema#string

P932

5963722

http://www.w3.org/2001/XMLSchema#string